http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100350737-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C225-30 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C225-30 |
| filingDate | 1999-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2002-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2002-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100350737-B1 |
| titleOfInvention | 2-Chloro-3-phenylamino-5-hydroxy-1,4-naphthalenedione Derivatives |
| abstract | The present invention provides a novel 2-chloro-3-phenylamino-5-hydroxy-1,4-naphthalenedione derivative of the general formula (I) having a platelet aggregation inhibitory activity, a method for preparing the same and an active ingredient thereof It relates to platelet aggregation inhibitors.n n n n n n n n Wheren n n R 1 , R 2 , R 3 are the same or different from each other hydrogen (H), fluorine (F), chloro (Cl), bromine (Br), acet (CH 3 CO), nitro (NO 2 ), trifluorine Romoxy (CF 3 ) group or ethylcarboxy (C 2 H 5 OCO) group.n n n The present invention provides 2-chloro-3-phenylamino-5-hydroxy-1,4-naphthalenedione derivatives and a method for preparing the same, and 2-chloro-3-phenylamino-5-hydroxy- according to the present invention. The 1,4-naphthalenedione derivative has a platelet aggregation inhibitory effect and can be used as a clinically useful platelet aggregation inhibitor. |
| priorityDate | 1999-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 52.